Virusbasierte Expression von Proteinen und Genen

EP4792829 19. August 2026

Anmelder: Sagitta Biotech 🇧🇪

Details

Veröffentlichungs-Nr.
EP4792829
Anmeldetag
18. Februar 2025
Veröffentlichung
19. August 2026
Rechtsraum
EP
Offizieller Volltext

Abstract

A nucleic acid molecule in the form of a plasmid comprising an origin of replication, a promoter for the transcription into viral RNA; a 3' NCT triplet upstream of regions for the insertion of gene(s) of interest, separated by Measeles virus intergenic regions, and one 5' NCT sharing at least 95% of identity with SEQ ID NO: 11 over its full-length, wherein the 3' NCT triplet shares at least 95% of identity with SEQ ID NO:14 over its full-length, the corresponding helper nucleic acid molecules, a process for the production of virosomes based on these nucleic acid based molecules, the obtained virosomes and their therapeutical uses.

Anmelder

Firma
Sagitta Biotech
Land
🇧🇪 Belgien

Vertreten von

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen